Global Mitochondrial Myopathies Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 121 pages | ID: G325A6E5A9DGEN
GlobalInfoResearch

Abstracts

Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. On biopsy, the muscle tissue of patients with these diseases usually demonstrate 'ragged red' muscle fibers. These ragged-red fibers contain mild accumulations of glycogen and neutral lipids, and may show an increased reactivity for succinate dehydrogenase and a decreased reactivity for cytochrome c oxidase.

SCOPE OF THE REPORT:

This report studies the Mitochondrial Myopathies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Mitochondrial Myopathies market by product type and applications/end industries.
The identification of patients with possible MM depends upon the investigation of multiple organ dysfunction in the clinical history, examination, and clinical tests. Although there is no disease-modifying therapy for MM, there are numerous points of clinical relevance that can reduce morbidity and improve quality of life for patients with these disorders.
The global Mitochondrial Myopathies market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Mitochondrial Myopathies.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Reata Pharmaceuticals
• Stealth Biotherapeutics
• Raptor Pharmaceutical
• Raym Genedx
• Neurovive Pharmaceutical

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Kearns-Sayre Syndrome
• Leigh Syndrome
• Mitochondrial Dna Depletion Syndrome
• Mitochondrial Encephalomyopathy
• Mitochondrial Neuro-Gastrointestinal Encephalomyopathy
• Myoclonus Epilepsy With Ragged Red Fibers
• Neuropathy, Ataxia And Retinitis Pigmentosa
• Pearson Syndrome, Progressive External Ophthalmoplegia

Market Segment by Applications, can be divided into

• Hospitals
• Clinics
• Disease Research and Development Institutes

Contents

1 MITOCHONDRIAL MYOPATHIES MARKET OVERVIEW

1.1 Product Overview and Scope of Mitochondrial Myopathies
1.2 Classification of Mitochondrial Myopathies by Types
  1.2.1 Global Mitochondrial Myopathies Revenue Comparison by Types (2017-2023)
  1.2.2 Global Mitochondrial Myopathies Revenue Market Share by Types in 2017
  1.2.3 Kearns-Sayre Syndrome
  1.2.4 Leigh Syndrome
  1.2.5 Mitochondrial Dna Depletion Syndrome
  1.2.6 Mitochondrial Encephalomyopathy
  1.2.7 Mitochondrial Neuro-Gastrointestinal Encephalomyopathy
  1.2.8 Myoclonus Epilepsy With Ragged Red Fibers
  1.2.9 Neuropathy, Ataxia And Retinitis Pigmentosa
  1.2.10 Pearson Syndrome, Progressive External Ophthalmoplegia
1.3 Global Mitochondrial Myopathies Market by Application
  1.3.1 Global Mitochondrial Myopathies Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Disease Research and Development Institutes
1.4 Global Mitochondrial Myopathies Market by Regions
  1.4.1 Global Mitochondrial Myopathies Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Mitochondrial Myopathies Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Mitochondrial Myopathies Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Mitochondrial Myopathies Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Mitochondrial Myopathies Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Mitochondrial Myopathies Status and Prospect (2013-2023)
1.5 Global Market Size of Mitochondrial Myopathies (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Reata Pharmaceuticals
  2.1.1 Business Overview
  2.1.2 Mitochondrial Myopathies Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Reata Pharmaceuticals Mitochondrial Myopathies Revenue, Gross Margin and Market Share (2016-2017)
2.2 Stealth Biotherapeutics
  2.2.1 Business Overview
  2.2.2 Mitochondrial Myopathies Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Stealth Biotherapeutics Mitochondrial Myopathies Revenue, Gross Margin and Market Share (2016-2017)
2.3 Raptor Pharmaceutical
  2.3.1 Business Overview
  2.3.2 Mitochondrial Myopathies Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Raptor Pharmaceutical Mitochondrial Myopathies Revenue, Gross Margin and Market Share (2016-2017)
2.4 Raym Genedx
  2.4.1 Business Overview
  2.4.2 Mitochondrial Myopathies Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Raym Genedx Mitochondrial Myopathies Revenue, Gross Margin and Market Share (2016-2017)
2.5 Neurovive Pharmaceutical
  2.5.1 Business Overview
  2.5.2 Mitochondrial Myopathies Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Neurovive Pharmaceutical Mitochondrial Myopathies Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL MITOCHONDRIAL MYOPATHIES MARKET COMPETITION, BY PLAYERS

3.1 Global Mitochondrial Myopathies Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Mitochondrial Myopathies Players Market Share
  3.2.2 Top 10 Mitochondrial Myopathies Players Market Share
3.3 Market Competition Trend

4 GLOBAL MITOCHONDRIAL MYOPATHIES MARKET SIZE BY REGIONS

4.1 Global Mitochondrial Myopathies Revenue and Market Share by Regions
4.2 North America Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
4.3 Europe Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
4.5 South America Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA MITOCHONDRIAL MYOPATHIES REVENUE BY COUNTRIES

5.1 North America Mitochondrial Myopathies Revenue by Countries (2013-2018)
5.2 USA Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
5.3 Canada Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
5.4 Mexico Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)

6 EUROPE MITOCHONDRIAL MYOPATHIES REVENUE BY COUNTRIES

6.1 Europe Mitochondrial Myopathies Revenue by Countries (2013-2018)
6.2 Germany Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
6.3 UK Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
6.4 France Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
6.5 Russia Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
6.6 Italy Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC MITOCHONDRIAL MYOPATHIES REVENUE BY COUNTRIES

7.1 Asia-Pacific Mitochondrial Myopathies Revenue by Countries (2013-2018)
7.2 China Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
7.3 Japan Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
7.4 Korea Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
7.5 India Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA MITOCHONDRIAL MYOPATHIES REVENUE BY COUNTRIES

8.1 South America Mitochondrial Myopathies Revenue by Countries (2013-2018)
8.2 Brazil Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
8.3 Argentina Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
8.4 Colombia Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE MITOCHONDRIAL MYOPATHIES BY COUNTRIES

9.1 Middle East and Africa Mitochondrial Myopathies Revenue by Countries (2013-2018)
9.2 Saudi Arabia Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
9.3 UAE Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
9.4 Egypt Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
9.5 Nigeria Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
9.6 South Africa Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)

10 GLOBAL MITOCHONDRIAL MYOPATHIES MARKET SEGMENT BY TYPE

10.1 Global Mitochondrial Myopathies Revenue and Market Share by Type (2013-2018)
10.2 Global Mitochondrial Myopathies Market Forecast by Type (2018-2023)
10.3 Kearns-Sayre Syndrome Revenue Growth Rate (2013-2023)
10.4 Leigh Syndrome Revenue Growth Rate (2013-2023)
10.5 Mitochondrial Dna Depletion Syndrome Revenue Growth Rate (2013-2023)
10.6 Mitochondrial Encephalomyopathy Revenue Growth Rate (2013-2023)
10.7 Mitochondrial Neuro-Gastrointestinal Encephalomyopathy Revenue Growth Rate (2013-2023)
10.8 Myoclonus Epilepsy With Ragged Red Fibers Revenue Growth Rate (2013-2023)
10.9 Neuropathy, Ataxia And Retinitis Pigmentosa Revenue Growth Rate (2013-2023)
10.10 Pearson Syndrome, Progressive External Ophthalmoplegia Revenue Growth Rate (2013-2023)

11 GLOBAL MITOCHONDRIAL MYOPATHIES MARKET SEGMENT BY APPLICATION

11.1 Global Mitochondrial Myopathies Revenue Market Share by Application (2013-2018)
11.2 Mitochondrial Myopathies Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Disease Research and Development Institutes Revenue Growth (2013-2018)

12 GLOBAL MITOCHONDRIAL MYOPATHIES MARKET SIZE FORECAST (2018-2023)

12.1 Global Mitochondrial Myopathies Market Size Forecast (2018-2023)
12.2 Global Mitochondrial Myopathies Market Forecast by Regions (2018-2023)
12.3 North America Mitochondrial Myopathies Revenue Market Forecast (2018-2023)
12.4 Europe Mitochondrial Myopathies Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Mitochondrial Myopathies Revenue Market Forecast (2018-2023)
12.6 South America Mitochondrial Myopathies Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Mitochondrial Myopathies Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Mitochondrial Myopathies Picture
Table Product Specifications of Mitochondrial Myopathies
Table Global Mitochondrial Myopathies and Revenue (Million USD) Market Split by Product Type
Figure Global Mitochondrial Myopathies Revenue Market Share by Types in 2017
Figure Kearns-Sayre Syndrome Picture
Figure Leigh Syndrome Picture
Figure Mitochondrial Dna Depletion Syndrome Picture
Figure Mitochondrial Encephalomyopathy Picture
Figure Mitochondrial Neuro-Gastrointestinal Encephalomyopathy Picture
Figure Myoclonus Epilepsy With Ragged Red Fibers Picture
Figure Neuropathy, Ataxia And Retinitis Pigmentosa Picture
Figure Pearson Syndrome, Progressive External Ophthalmoplegia Picture
Table Global Mitochondrial Myopathies Revenue (Million USD) by Application (2013-2023)
Figure Mitochondrial Myopathies Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Disease Research and Development Institutes Picture
Table Global Market Mitochondrial Myopathies Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Mitochondrial Myopathies Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Mitochondrial Myopathies Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Mitochondrial Myopathies Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Mitochondrial Myopathies Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Mitochondrial Myopathies Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Mitochondrial Myopathies Revenue (Million USD) and Growth Rate (2013-2023)
Table Reata Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Reata Pharmaceuticals Mitochondrial Myopathies Type and Applications
Table Reata Pharmaceuticals Mitochondrial Myopathies Revenue, Gross Margin and Market Share (2016-2017)
Table Stealth Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table Stealth Biotherapeutics Mitochondrial Myopathies Type and Applications
Table Stealth Biotherapeutics Mitochondrial Myopathies Revenue, Gross Margin and Market Share (2016-2017)
Table Raptor Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Raptor Pharmaceutical Mitochondrial Myopathies Type and Applications
Table Raptor Pharmaceutical Mitochondrial Myopathies Revenue, Gross Margin and Market Share (2016-2017)
Table Raym Genedx Basic Information, Manufacturing Base and Competitors
Table Raym Genedx Mitochondrial Myopathies Type and Applications
Table Raym Genedx Mitochondrial Myopathies Revenue, Gross Margin and Market Share (2016-2017)
Table Neurovive Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Neurovive Pharmaceutical Mitochondrial Myopathies Type and Applications
Table Neurovive Pharmaceutical Mitochondrial Myopathies Revenue, Gross Margin and Market Share (2016-2017)
Table Global Mitochondrial Myopathies Revenue (Million USD) by Players (2013-2018)
Table Global Mitochondrial Myopathies Revenue Share by Players (2013-2018)
Figure Global Mitochondrial Myopathies Revenue Share by Players in 2016
Figure Global Mitochondrial Myopathies Revenue Share by Players in 2017
Figure Global Top 5 Players Mitochondrial Myopathies Revenue Market Share in 2017
Figure Global Top 10 Players Mitochondrial Myopathies Revenue Market Share in 2017
Figure Global Mitochondrial Myopathies Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Mitochondrial Myopathies Revenue (Million USD) by Regions (2013-2018)
Table Global Mitochondrial Myopathies Revenue Market Share by Regions (2013-2018)
Figure Global Mitochondrial Myopathies Revenue Market Share by Regions (2013-2018)
Figure Global Mitochondrial Myopathies Revenue Market Share by Regions in 2017
Figure North America Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure Europe Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure South America Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Table North America Mitochondrial Myopathies Revenue by Countries (2013-2018)
Table North America Mitochondrial Myopathies Revenue Market Share by Countries (2013-2018)
Figure North America Mitochondrial Myopathies Revenue Market Share by Countries (2013-2018)
Figure North America Mitochondrial Myopathies Revenue Market Share by Countries in 2017
Figure USA Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure Canada Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure Mexico Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Table Europe Mitochondrial Myopathies Revenue (Million USD) by Countries (2013-2018)
Figure Europe Mitochondrial Myopathies Revenue Market Share by Countries (2013-2018)
Figure Europe Mitochondrial Myopathies Revenue Market Share by Countries in 2017
Figure Germany Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure UK Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure France Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure Russia Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure Italy Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Mitochondrial Myopathies Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Mitochondrial Myopathies Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Mitochondrial Myopathies Revenue Market Share by Countries in 2017
Figure China Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure Japan Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure Korea Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure India Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Table South America Mitochondrial Myopathies Revenue by Countries (2013-2018)
Table South America Mitochondrial Myopathies Revenue Market Share by Countries (2013-2018)
Figure South America Mitochondrial Myopathies Revenue Market Share by Countries (2013-2018)
Figure South America Mitochondrial Myopathies Revenue Market Share by Countries in 2017
Figure Brazil Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure Argentina Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure Colombia Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Mitochondrial Myopathies Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Mitochondrial Myopathies Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Mitochondrial Myopathies Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Mitochondrial Myopathies Revenue Market Share by Countries in 2017
Figure Saudi Arabia Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure UAE Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure Egypt Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure Nigeria Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Figure South Africa Mitochondrial Myopathies Revenue and Growth Rate (2013-2018)
Table Global Mitochondrial Myopathies Revenue (Million USD) by Type (2013-2018)
Table Global Mitochondrial Myopathies Revenue Share by Type (2013-2018)
Figure Global Mitochondrial Myopathies Revenue Share by Type (2013-2018)
Figure Global Mitochondrial Myopathies Revenue Share by Type in 2017
Table Global Mitochondrial Myopathies Revenue Forecast by Type (2018-2023)
Figure Global Mitochondrial Myopathies Market Share Forecast by Type (2018-2023)
Figure Global Kearns-Sayre Syndrome Revenue Growth Rate (2013-2018)
Figure Global Leigh Syndrome Revenue Growth Rate (2013-2018)
Figure Global Mitochondrial Dna Depletion Syndrome Revenue Growth Rate (2013-2018)
Figure Global Mitochondrial Encephalomyopathy Revenue Growth Rate (2013-2018)
Figure Global Mitochondrial Neuro-Gastrointestinal Encephalomyopathy Revenue Growth Rate (2013-2018)
Figure Global Myoclonus Epilepsy With Ragged Red Fibers Revenue Growth Rate (2013-2018)
Figure Global Neuropathy, Ataxia And Retinitis Pigmentosa Revenue Growth Rate (2013-2018)
Figure Global Pearson Syndrome, Progressive External Ophthalmoplegia Revenue Growth Rate (2013-2018)
Table Global Mitochondrial Myopathies Revenue by Application (2013-2018)
Table Global Mitochondrial Myopathies Revenue Share by Application (2013-2018)
Figure Global Mitochondrial Myopathies Revenue Share by Application (2013-2018)
Figure Global Mitochondrial Myopathies Revenue Share by Application in 2017
Table Global Mitochondrial Myopathies Revenue Forecast by Application (2018-2023)
Figure Global Mitochondrial Myopathies Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Disease Research and Development Institutes Revenue Growth Rate (2013-2018)
Figure Global Mitochondrial Myopathies Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Mitochondrial Myopathies Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Mitochondrial Myopathies Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Mitochondrial Myopathies Revenue Market Forecast (2018-2023)
Figure Europe Mitochondrial Myopathies Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Mitochondrial Myopathies Revenue Market Forecast (2018-2023)
Figure South America Mitochondrial Myopathies Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Mitochondrial Myopathies Revenue Market Forecast (2018-2023)